MetLife

Forecast & Rating18 analysts currently cover MetLife, with about 72.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $105.75, about 8.7% upside from the current price of $97.25. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 57.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study MetLife closely still see room for the stock to rise. Data as of Sep 22, 2026; for reference only and not investment advice.